Selected research
Industry Research
High Throughput Screening (HTS) Service Industry Research Report 2026
Market perspective
The global High Throughput Screening (HTS) Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the High Throughput Screening (HTS) Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the High Throughput Screening (HTS) Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the High Throughput Screening (HTS) Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of High Throughput Screening (HTS) Service include Eurofins Discovery, Charles River Laboratories, Axcelead, NUVISAN, Axxam S.p.A., Evotec, Selvita, Azenta Life Sciences and Bienta (Enamine), among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global High Throughput Screening (HTS) Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to High Throughput Screening (HTS) Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
High Throughput Screening (HTS) Service Market by Company
Eurofins Discovery
Charles River Laboratories
Axcelead
NUVISAN
Axxam S.p.A.
Evotec
Selvita
Azenta Life Sciences
Bienta (Enamine)
Cayman Chemical
Creative Biolabs
Creative Bioarray
BOC Sciences
MEDICILON
Domainex
Creative Diagnostics
Multispan
AntalGenics
Creative Biostructure
BPS Bioscience
High Throughput Screening (HTS) Service Segment by Type
Chemical-based HTS Service
Biological-based HTS Service
Cell-based HTS Service
Genetic-based HTS Service
High Throughput Screening (HTS) Service Segment by Application
Pharmaceutical Industry
Universities and Scientific Research Institutions
High Throughput Screening (HTS) Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global High Throughput Screening (HTS) Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of High Throughput Screening (HTS) Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of High Throughput Screening (HTS) Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of High Throughput Screening (HTS) Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Chemical-based HTS Service
- Biological-based HTS Service
- Cell-based HTS Service
- Genetic-based HTS Service
Applications
- Pharmaceutical Industry
- Universities and Scientific Research Institutions
Companies covered
- Eurofins Discovery
- Charles River Laboratories
- Axcelead
- NUVISAN
- Axxam S.p.A.
- Evotec
- Selvita
- Azenta Life Sciences
- Bienta (Enamine)
- Cayman Chemical
- Creative Biolabs
- Creative Bioarray
- BOC Sciences
- MEDICILON
- Domainex
- Creative Diagnostics
- Multispan
- AntalGenics
- Creative Biostructure
- BPS Bioscience
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 High Throughput Screening (HTS) Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Chemical-based HTS Service
- 2.2.3 Biological-based HTS Service
- 2.2.4 Cell-based HTS Service
- 2.2.5 Genetic-based HTS Service
- 2.3 High Throughput Screening (HTS) Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Industry
- 2.3.3 Universities and Scientific Research Institutions
- 2.4 Assumptions and Limitations
3 High Throughput Screening (HTS) Service Breakdown Data by Type
- 3.1 Global High Throughput Screening (HTS) Service Historic Market Size by Type (2021-2026)
- 3.2 Global High Throughput Screening (HTS) Service Forecasted Market Size by Type (2027-2032)
4 High Throughput Screening (HTS) Service Breakdown Data by Application
- 4.1 Global High Throughput Screening (HTS) Service Historic Market Size by Application (2021-2026)
- 4.2 Global High Throughput Screening (HTS) Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global High Throughput Screening (HTS) Service Market Perspective (2021-2032)
- 5.2 Global High Throughput Screening (HTS) Service Growth Trends by Region
- 5.2.1 Global High Throughput Screening (HTS) Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 High Throughput Screening (HTS) Service Historic Market Size by Region (2021-2026)
- 5.2.3 High Throughput Screening (HTS) Service Forecasted Market Size by Region (2027-2032)
- 5.3 High Throughput Screening (HTS) Service Market Dynamics
- 5.3.1 High Throughput Screening (HTS) Service Industry Trends
- 5.3.2 High Throughput Screening (HTS) Service Market Drivers
- 5.3.3 High Throughput Screening (HTS) Service Market Challenges
- 5.3.4 High Throughput Screening (HTS) Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top High Throughput Screening (HTS) Service Players by Revenue
- 6.1.1 Global Top High Throughput Screening (HTS) Service Players by Revenue (2021-2026)
- 6.1.2 Global High Throughput Screening (HTS) Service Revenue Market Share by Players (2021-2026)
- 6.2 Global High Throughput Screening (HTS) Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of High Throughput Screening (HTS) Service Head Office and Area Served
- 6.4 Global High Throughput Screening (HTS) Service Players, Product Type & Application
- 6.5 Global High Throughput Screening (HTS) Service Manufacturers Established Date
- 6.6 Global High Throughput Screening (HTS) Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America High Throughput Screening (HTS) Service Market Size (2021-2032)
- 7.2 North America High Throughput Screening (HTS) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America High Throughput Screening (HTS) Service Market Size by Country (2021-2026)
- 7.4 North America High Throughput Screening (HTS) Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe High Throughput Screening (HTS) Service Market Size (2021-2032)
- 8.2 Europe High Throughput Screening (HTS) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe High Throughput Screening (HTS) Service Market Size by Country (2021-2026)
- 8.4 Europe High Throughput Screening (HTS) Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific High Throughput Screening (HTS) Service Market Size (2021-2032)
- 9.2 Asia-Pacific High Throughput Screening (HTS) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific High Throughput Screening (HTS) Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific High Throughput Screening (HTS) Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America High Throughput Screening (HTS) Service Market Size (2021-2032)
- 10.2 South America High Throughput Screening (HTS) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America High Throughput Screening (HTS) Service Market Size by Country (2021-2026)
- 10.4 South America High Throughput Screening (HTS) Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa High Throughput Screening (HTS) Service Market Size (2021-2032)
- 11.2 Middle East & Africa High Throughput Screening (HTS) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa High Throughput Screening (HTS) Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa High Throughput Screening (HTS) Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eurofins Discovery
- 12.1.1 Eurofins Discovery Company Information
- 12.1.2 Eurofins Discovery Business Overview
- 12.1.3 Eurofins Discovery Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.1.4 Eurofins Discovery High Throughput Screening (HTS) Service Product Portfolio
- 12.1.5 Eurofins Discovery Recent Developments
- 12.2 Charles River Laboratories
- 12.2.1 Charles River Laboratories Company Information
- 12.2.2 Charles River Laboratories Business Overview
- 12.2.3 Charles River Laboratories Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.2.4 Charles River Laboratories High Throughput Screening (HTS) Service Product Portfolio
- 12.2.5 Charles River Laboratories Recent Developments
- 12.3 Axcelead
- 12.3.1 Axcelead Company Information
- 12.3.2 Axcelead Business Overview
- 12.3.3 Axcelead Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.3.4 Axcelead High Throughput Screening (HTS) Service Product Portfolio
- 12.3.5 Axcelead Recent Developments
- 12.4 NUVISAN
- 12.4.1 NUVISAN Company Information
- 12.4.2 NUVISAN Business Overview
- 12.4.3 NUVISAN Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.4.4 NUVISAN High Throughput Screening (HTS) Service Product Portfolio
- 12.4.5 NUVISAN Recent Developments
- 12.5 Axxam S.p.A.
- 12.5.1 Axxam S.p.A. Company Information
- 12.5.2 Axxam S.p.A. Business Overview
- 12.5.3 Axxam S.p.A. Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.5.4 Axxam S.p.A. High Throughput Screening (HTS) Service Product Portfolio
- 12.5.5 Axxam S.p.A. Recent Developments
- 12.6 Evotec
- 12.6.1 Evotec Company Information
- 12.6.2 Evotec Business Overview
- 12.6.3 Evotec Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.6.4 Evotec High Throughput Screening (HTS) Service Product Portfolio
- 12.6.5 Evotec Recent Developments
- 12.7 Selvita
- 12.7.1 Selvita Company Information
- 12.7.2 Selvita Business Overview
- 12.7.3 Selvita Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.7.4 Selvita High Throughput Screening (HTS) Service Product Portfolio
- 12.7.5 Selvita Recent Developments
- 12.8 Azenta Life Sciences
- 12.8.1 Azenta Life Sciences Company Information
- 12.8.2 Azenta Life Sciences Business Overview
- 12.8.3 Azenta Life Sciences Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.8.4 Azenta Life Sciences High Throughput Screening (HTS) Service Product Portfolio
- 12.8.5 Azenta Life Sciences Recent Developments
- 12.9 Bienta (Enamine)
- 12.9.1 Bienta (Enamine) Company Information
- 12.9.2 Bienta (Enamine) Business Overview
- 12.9.3 Bienta (Enamine) Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.9.4 Bienta (Enamine) High Throughput Screening (HTS) Service Product Portfolio
- 12.9.5 Bienta (Enamine) Recent Developments
- 12.10 Cayman Chemical
- 12.10.1 Cayman Chemical Company Information
- 12.10.2 Cayman Chemical Business Overview
- 12.10.3 Cayman Chemical Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.10.4 Cayman Chemical High Throughput Screening (HTS) Service Product Portfolio
- 12.10.5 Cayman Chemical Recent Developments
- 12.11 Creative Biolabs
- 12.11.1 Creative Biolabs Company Information
- 12.11.2 Creative Biolabs Business Overview
- 12.11.3 Creative Biolabs Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.11.4 Creative Biolabs High Throughput Screening (HTS) Service Product Portfolio
- 12.11.5 Creative Biolabs Recent Developments
- 12.12 Creative Bioarray
- 12.12.1 Creative Bioarray Company Information
- 12.12.2 Creative Bioarray Business Overview
- 12.12.3 Creative Bioarray Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.12.4 Creative Bioarray High Throughput Screening (HTS) Service Product Portfolio
- 12.12.5 Creative Bioarray Recent Developments
- 12.13 BOC Sciences
- 12.13.1 BOC Sciences Company Information
- 12.13.2 BOC Sciences Business Overview
- 12.13.3 BOC Sciences Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.13.4 BOC Sciences High Throughput Screening (HTS) Service Product Portfolio
- 12.13.5 BOC Sciences Recent Developments
- 12.14 MEDICILON
- 12.14.1 MEDICILON Company Information
- 12.14.2 MEDICILON Business Overview
- 12.14.3 MEDICILON Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.14.4 MEDICILON High Throughput Screening (HTS) Service Product Portfolio
- 12.14.5 MEDICILON Recent Developments
- 12.15 Domainex
- 12.15.1 Domainex Company Information
- 12.15.2 Domainex Business Overview
- 12.15.3 Domainex Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.15.4 Domainex High Throughput Screening (HTS) Service Product Portfolio
- 12.15.5 Domainex Recent Developments
- 12.16 Creative Diagnostics
- 12.16.1 Creative Diagnostics Company Information
- 12.16.2 Creative Diagnostics Business Overview
- 12.16.3 Creative Diagnostics Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.16.4 Creative Diagnostics High Throughput Screening (HTS) Service Product Portfolio
- 12.16.5 Creative Diagnostics Recent Developments
- 12.17 Multispan
- 12.17.1 Multispan Company Information
- 12.17.2 Multispan Business Overview
- 12.17.3 Multispan Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.17.4 Multispan High Throughput Screening (HTS) Service Product Portfolio
- 12.17.5 Multispan Recent Developments
- 12.18 AntalGenics
- 12.18.1 AntalGenics Company Information
- 12.18.2 AntalGenics Business Overview
- 12.18.3 AntalGenics Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.18.4 AntalGenics High Throughput Screening (HTS) Service Product Portfolio
- 12.18.5 AntalGenics Recent Developments
- 12.19 Creative Biostructure
- 12.19.1 Creative Biostructure Company Information
- 12.19.2 Creative Biostructure Business Overview
- 12.19.3 Creative Biostructure Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.19.4 Creative Biostructure High Throughput Screening (HTS) Service Product Portfolio
- 12.19.5 Creative Biostructure Recent Developments
- 12.20 BPS Bioscience
- 12.20.1 BPS Bioscience Company Information
- 12.20.2 BPS Bioscience Business Overview
- 12.20.3 BPS Bioscience Revenue in High Throughput Screening (HTS) Service Business (2021-2026)
- 12.20.4 BPS Bioscience High Throughput Screening (HTS) Service Product Portfolio
- 12.20.5 BPS Bioscience Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst